Fig. 7: LINC00969 contributes to NSCLC tumorigenesis. | Cell Death & Disease

Fig. 7: LINC00969 contributes to NSCLC tumorigenesis.

From: LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer

Fig. 7: LINC00969 contributes to NSCLC tumorigenesis.

A qRT-PCR analysis of LINC00969 expression in NSCLC cells (PC9, HCC827, A549 and SPCA1) transfected with siRNAs. B–D MTT, colony formation and EDU assays were performed to assess the proliferation of NSCLC cells after transfection. E After transfection, NSCLC cells were subjected to Transwell assays to evaluate changes in the migration capability. All bars show the mean ± SD of three independent experiments. **P < 0.01.

Back to article page